Cited by 134Amyotrophic Lateral Sclerosis ResearchPain Mechanisms and TreatmentsPain Management and Opioid Use

Pain in amyotrophic lateral sclerosis

Open access
Chiò, Adriano, Mora, Gabriele, Lauria, Giuseppe·2017·The Lancet Neurology

Abstract

Pain is a largely neglected symptom in patients with amyotrophic lateral sclerosis (ALS) although it is reported by most of these patients. It occurs at all stages of the disease and can be an onset symptom preceding motor dysfunction. Pain is correlated with a deterioration in patients' quality of life and increased prevalence of depression. In the later stages of ALS, pain can be severe enough to require increased use of sedative and analgesic drugs, and is among the events that predict clinical deterioration and death. The site of pain depends on the pain type or underlying mechanism (eg, painful cramps, nociceptive pain, or neuropathic pain). Given the multifactorial nature of pain in patients with ALS, different treatments have been suggested, ranging from non-steroidal anti-inflammatory drugs, drugs for neuropathic pain, opioids, and cannabinoids, to physical therapy strategies and preventive assistive devices. Further understanding of the pathophysiology is crucial to drive assessment in clinical trials of therapeutic strategies targeted at specific mechanisms and studies of individualised therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(16)30358-1

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [40]40. Moisset X, Cornut-Chauvinc C, Clavelou P, Pereira B, Dallel R, Guy N. Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study. Palliat Med 2016; 30(5): 486-94.
  2. [73]73. Meyer RA, Campbell IT, Raja SN. Peripheral neural mechanisms of nociception. In: Wall PD, Melzack R, eds. Textbook of Pain. Edinburgh: Churchill Livingstone.; 1995: 13-44.
  3. [86]86. Kukkar A, Bali A, Singh N, Jaggi AS. Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res 2013; 36(3): 237-51.
  4. [87]87. Verma V, Singh N, Singh Jaggi A. Pregabalin in neuropathic pain: evidences and possible mechanisms. Curr Neuropharmacol 2014; 12(1): 44-56.

Cited by

Sorted by citations

Authors
Chiò, A., Mora, G., & Lauria, G.
Affiliations
  • University of Turin (IT)
  • Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
Corresponding author
Chiò, Adriano
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2017-02
Volume
16
Issue
2
Pages
144-157
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2560505659
Cited by
134
References
109
Citations by year
2026: 6 · 2025: 12 · 2024: 20 · 2023: 19 · 2022: 12 · 2021: 26 · 2020: 15 · 2019: 8 · 2018: 10 · 2017: 6
FWCI
1.11
Type
journal article
Language
en
Open access
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
Funders
  • Ministero della Salute
  • Economic and Social Research Council (ES/L008238/1)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
amyotrophic lateral sclerosis, pain, neuropathic pain, nociceptive pain, quality of life, depression, analgesic use, opioids, cannabinoids, nonsteroidal anti-inflammatory drugs, pain pathophysiology
MeSH terms
Amyotrophic Lateral Sclerosis, Humans, Muscle Cramp, Neuralgia, Nociceptive Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review